Bacterial DNA containing unmethylated CpG dinucleotides (CpG DNA) has recently been recognized as an important immune-activating agent and holds strong promise for therapeutic treatment of cancer, allergy, and infection. Although it is known now that CpG DNA functions through a signaling cascade involving Toll-like receptor 9 and associated proteins, culminating in activation of transcription factors NF-kappaB and AP-1, as well as subsequent induction of various immune-regulatory genes, studies on how host cells differentiate CpG DNA from non-CpG DNA or methylated CpG DNA have been relatively limited. My long-term goal is to contribute fundamental knowledge in molecular mechanisms of host immune responses and their role in treatment of disease. The objective of this project is to define mechanism(s) by which CpG DNA induces expression of inflammatory mediators in mouse macrophages. The central hypothesis of this research project is that the capacity of being methylated enables CpG DNA to compete with host cell genomic DNA as a substrate for DNA methyltransferase I and causes reduced methylation of genomic DNA, which leads to elevated gene expression (possibly through enhancing accessibility of upstream regulatory regions of these genes to activated transcription factors). Since our preliminary data indicate CpG DNA induces rapid expression of transcription factor C/EBPdelta, which has binding sites in the promoters of a number of proinflammatory genes, we also hypothesize that C/EBPdelta mediates inflammatory gene induction in response to CpG DNA. To test these hypotheses, the following specific aims are proposed: 1. To define the role of CpG DNA in regulation of mouse macrophage inflammatory gene expression within the framework of intracellular methylation events. 2. To determine the extent to which treatment of macrophages with CpG DNA results in reduced methylation of 5' regulatory regions of specific inflammatory genes and, as a result, causes increased expression of these genes. 3. To determine the role of transcription factor C/EBPdelta in induction of inflammatory genes in response to CpG DNA. The successful completion of this research will contribute to the development of CpG DNA as a novel therapeutic agent against cancer, allergy, and infection.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
1R01AI054962-01
Application #
6605162
Study Section
Experimental Immunology Study Section (EI)
Program Officer
Bocek, Petr
Project Start
2003-05-01
Project End
2006-04-30
Budget Start
2003-05-01
Budget End
2004-04-30
Support Year
1
Fiscal Year
2003
Total Cost
$217,500
Indirect Cost
Name
University of Missouri Kansas City
Department
Other Basic Sciences
Type
Schools of Medicine
DUNS #
010989619
City
Kansas City
State
MO
Country
United States
Zip Code
64110
Qureshi, Asaf A; Guan, Xiu Qin; Reis, Julia C et al. (2012) Inhibition of nitric oxide and inflammatory cytokines in LPS-stimulated murine macrophages by resveratrol, a potent proteasome inhibitor. Lipids Health Dis 11:76
Rockwell, Cheryl E; Monaco, John J; Qureshi, Nilofer (2012) A critical role for the inducible proteasomal subunits LMP7 and MECL1 in cytokine production by activated murine splenocytes. Pharmacology 89:117-26
Qureshi, Asaf A; Reis, Julia C; Qureshi, Nilofer et al. (2011) ?-Tocotrienol and quercetin reduce serum levels of nitric oxide and lipid parameters in female chickens. Lipids Health Dis 10:39
Qureshi, Asaf A; Tan, Xiaoyu; Reis, Julia C et al. (2011) Inhibition of nitric oxide in LPS-stimulated macrophages of young and senescent mice by ?-tocotrienol and quercetin. Lipids Health Dis 10:239
Qureshi, Asaf A; Tan, Xiaoyu; Reis, Julia C et al. (2011) Suppression of nitric oxide induction and pro-inflammatory cytokines by novel proteasome inhibitors in various experimental models. Lipids Health Dis 10:177
Gao, Jian Jun; Shen, Jing; Kolbert, Christopher et al. (2010) The proteasome regulates bacterial CpG DNA-induced signaling pathways in murine macrophages. Shock 34:390-401
Rockwell, Cheryl E; Morrison, David C; Qureshi, Nilofer (2009) Lipid A-mediated tolerance and cancer therapy. Adv Exp Med Biol 667:81-99
Reis, Julia; Tan, Xiaoyu; Yang, Rongjie et al. (2008) A combination of proteasome inhibitors and antibiotics prevents lethality in a septic shock model. Innate Immun 14:319-29